Abstract

<h3>Introduction</h3> Genome wide expression analysis using microarray allows a comprehensive picture of gene expression at the tissue and cellular level. The aim of this study was to investigate the differential expression of 26 genes recently identified by Barrett <i>et al</i> as being associated with ulcerative colitis (UC).1 <h3>Methods</h3> 67 Ulcerative colitis patients (UC) and 31 controls (HC) were studied. 129 UC and 73 HC paired endoscopic biopsies were taken from specific anatomical locations for RNA extraction and histology assessment. Expression signatures were investigated using 39 probes representing the 26 genes using the Agilent microarray platform. <h3>Results</h3> When all the UC biopsies were compared to controls MST1 was the most dysregulated gene- fold change (FC) −1.64, p &lt;0.00001 in the UC biopsies. HERC2 was also downregulated in the UC biopsies (FC −1.2, p &lt;0.00001) as was CCNY (FC −1.2, p=0.0001). TNFRSF6B was significantly upregulated (FC +1.2, p=0.005). When inflamed and non-inflamed descending and sigmoid colon UC biopsies were compared TNFRSF6B was upregulated (FC +2.98, p &lt;0.00001) as was MHC (FC +1.88, p=0.027), the novel susceptibility genes LAMB1 (FC +1.23, p=0.0058), HNF4A (FC +1.23, p=0.024) and ARPC2 (FC +1.20, p=0.01). MST1 (FC −1.76, p=0.015) and CCNY (FC −1.42, p=0.001) were downregulated in the inflamed UC biopsies. HERC2 was the only significantly dysregulated gene when non-inflamed UC and control biopsies were compared (FC −1.20, p=0.0028) and was downregulated in UC. <h3>Conclusion</h3> Disease and inflammation dependent expression changes were observed in a number of the UC genome wide expression scan susceptibility genes further implicating them in the pathogenesis of UC.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.